Molecular imaging in the development of a novel treatment paradig.pdf (1.1 MB)
Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary.
Version 2 2021-10-18, 11:44
Version 1 2019-11-22, 17:05
journal contribution
posted on 2019-11-22, 17:05 authored by Monika A. Jarzabek, Kieron J. Sweeney, Rhys L. Evans, Andreas H. Jacobs, Roger Stupp, Donncha F. O'Brien, Mitchel S. Berger, Jochen HM Prehn, Annette ByrneCurrent therapeutic strategies against glioblastoma (GBM) have failed to prevent disease progression and recurrence effectively. The part played by molecular imaging (MI) in the development of novel therapies has gained increasing traction in recent years. For the first time, using expertise from an integrated multidisciplinary group of authors, herein we present a comprehensive evaluation of state-of-the-art GBM imaging and explore how advances facilitate the emergence of new treatment options. We propose a novel next-generation treatment paradigm based on the targeting of multiple hallmarks of cancer evolution that will heavily rely on MI.